MarketersMEDIA / Newsroom / Key Trends in Vaccine Market Dominated by Pneumococcal Disease, Influenza, Hepatitis and to Reach US$ 49.27 Billion by 2022

Key Trends in Vaccine Market Dominated by Pneumococcal Disease, Influenza, Hepatitis and to Reach US$ 49.27 Billion by 2022

Share This Press Release

Vaccines market into technology, type, disease indication, route of administration, patient type, & region. Based on technology, vaccines market is segmented into conjugate vaccines, inactivated & subunit vaccines, live attenuated vaccines, recombinant vaccines, and toxoid vaccines.

Vaccines market is expected to reach USD 50.42 billion by 2023 from USD 36.45 billion in 2018, at a CAGR of 6.7%. Factors like rising prevalence of diseases, increasing government and nongovernment funding for vaccine development, & increasing company initiatives to enhance R&D are driving vaccines market.

Access Sample Papers of Vaccine Market spread across 204 Pages, Profiling 15 Companies and Supported with 92 Tables and 52 Figures is now available at .

North America is expected to account for the largest share of the market followed by Europe. However, Asia is expected to register the highest CAGR during the forecast period. The high growth in this segment is attributed to the increasing investments by companies in India and China, rising disposable income, growing number of awareness programs and symposia, and growing venture capital investments.

List of companies profiled in the report
• GlaxoSmithKline plc
• Pfizer, Inc.
• Merck & Co., Inc.
• Sanofi Pasteur SA
• CSL Limited
• Emergent BioSolutions, Inc.
• Johnson & Johnson
• MedImmune, LLC
• Astellas Pharma Inc.
• Serum Institute of India
• Bavarian Nordic
• Mitsubishi Tanabe Pharma Corporation
• Daiichi Sankyo Company, Limited
• Protein Science Corporation
• Panacea Biotec

Get More Information on Global Vaccine Market Research Report Now at .

Report provides an overview of vaccines market. It aims at estimating the market size and future growth potential of this market across different segments such as technology, type, disease indication, route of administration, end user, and region.

Vaccine Market, By Technology
1 Introduction
2 Conjugate Vaccines
3 Inactivated and Subunit Vaccines
4 Live Attenuated Vaccines
5 Recombinant Vaccines
6 Toxoid Vaccines

Vaccine Market, By Route of Administration
1 Introduction
2 Intramuscular and Subcutaneous Administration
3 Oral Administration
4 Other Routes of Administration

Click now for more Details, Queries, Other Information on this study “Vaccines Market by Technology (Live, Toxoid, Recombinant), Disease (Pneumococcal, Influenza, DTP, HPV, Hepatitis, Meningococcal, Rotavirus, Polio, MMR, Varicella, Dengue), Route (IM/SC, Oral), Patient (Pediatric, Adult), Type - Global Forecast to 2023” report @ .

The vaccines market is segmented into intramuscular and subcutaneous administration, oral administration, and other routes of administration. The intramuscular and subcutaneous administration segment is expected to hold the largest share of the vaccines market, in 2018.

Get the Free Analysis of Knowledge Store Now at .

The growth of this segment is attributed to benefits associated with this mode of administration such as faster absorption of medication in blood, and lower rate of injection site reactions.

Contact Info:
Name: Mr. Hrishikesh
Organization: ReportsnReports
Address: Tower B5, Office 101, Magarpatta City SEZ, Pune-411013, India
Phone: +1 888 391 5441

Source URL:

Source: MarketersMedia

Release ID: 392032

Latest Releases

Subscribe and Receive exclusive insider tips and tricks on Press Release.

Follow Us

Copyright © 2012 - 2019 MarketersMEDIA – Press Release Distribution Services – News Release Distribution Services. All Rights Reserved.

Powered by Semantics BigData Analytics (SBDA).